• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>BMC Ophthalmology >Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
【24h】

Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis

机译：白内障手术与Behcet病葡萄膜炎患者的微切口玻璃体切除术相结合

获取原文
       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

This study sought to report the outcomes of a combined cataract extraction, intraocular lens (IOL) insertion and micro-incision vitrectomy (MIVS) procedure for the treatment of Behcet uveitis. This investigation involved the retrospective evaluation of a case series of patients with Behcet uveitis who underwent cataract extraction, IOL insertion and MIVS in a single surgical session at the same institution between January 2013 and November 2016. Outcome measures included visual acuity, inflammatory reaction, systemic anti-inflammatory medications, intraocular pressure (IOP) and complications. Seven eyes of seven patients with a mean age of 39.00?±?5.54?years (range, 32 to 48?years) and a mean follow-up duration of 13.57?±?5.83?months (range, 6 to 24?months) were studied; five patients with a history of well-controlled uveitis were included. All patients underwent cataract extraction and IOL implantation combined with MIVS. All patients received postoperative steroids, which were slowly tapered during the weeks after surgery. There were no significant complications related to the surgery. Overall, best-corrected visual acuity (BCVA) was improved from log MAR (logarithm of the minimum angle of resolution) 1.67?±?0.67 preoperatively to log MAR 0.74?±?0.35 postoperatively; this improvement was statistically significant (p??0.05). All eyes were deemed quiet at follow-up, and no patients required the escalation of therapy for long-term uveitis control. This retrospective series indicates that a procedure that combines phacoemulsification, IOL implantation and MIVS is a feasible technique for the removal of cataracts and pathologic vitreous in eyes with Behcet uveitis. This approach can restore vision without obvious complications.
机译：本研究寻求报告组合白内障萃取，眼内透镜（IOL）插入和微切除术（MIV）治疗Behcet葡萄膜炎的结果的结果。该调查涉及对在2013年1月至2016年1月至2016年1月至11月期间在同一机构的白内障提取，IOL插入和MIV中进行白内障u型患者的案例系列患者的回顾性评价。结果措施包括视力，炎症反应，系统性抗炎药，眼压（IOP）和并发症。七只患者的七个患者，平均年龄为39.00？±5.54？年（范围，32至48岁）和平均随访时间为13.57？±5.83？月（范围，6到24个月）研究;包括有良好控制的葡萄膜炎病史的五名患者。所有患者都接受白内障萃取和IOL植入联合MIV。所有患者均接受术后类固醇，在手术后几周慢慢逐渐变细。与手术没有显着的并发症。总的来说，从LOG MAR（分辨率最小角度的对数）改善了最佳校正的视力（BCVA）1.67？±0.67术前日志0.74？±0.35术后;这种改善在统计学上是显着的（P？<？0.05）。所有的眼睛都被视为安静，在随访中，没有患者需要对长期葡萄炎控制进行治疗的升级。该回顾性系列表明，将奇异乳化，IOL植入和MIV组合的过程是一种可行的技术，用于去除Behcet葡萄质炎的眼睛中的白内障和病理玻璃体。这种方法可以恢复视觉而没有明显并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号